News Link: Sputnik V Vaccine To Be Produced In India – By MK ( Editor)
Russia’s Sovereign Wealth Fund and Indian pharmaceutical company Hetero have come to an agreement. They produce over 100 million doses per year in India of the Sputnik V vaccine against COVID-19.
Hetero and the Russian Direct Investment Fund (RDIF), which has been backing the vaccine and marketing it globally. Plan to start production of Sputnik V in India at the beginning of 2021, the statement said.
Phase II-III trials are ongoing in India, the statement said. Drugmaker Dr Reddy’s Laboratories Ltd has said it expects late-stage trials to be completed by as early as March 2021
Read More News at Medical Segment
Sputnik V Vaccine To Be Produced In India. Sputnik V Vaccine To Be Produced In India
Russia’s Sovereign Wealth Fund and Indian pharmaceutical company Hetero have come to an agreement. They produce over 100 million doses per year in India of the Sputnik V vaccine against COVID-19. Hetero and the Russian Direct Investment Fund (RDIF), which has been backing the vaccine and marketing it globally. Plan to start production of Sputnik V in India at the beginning of 2021, the statement said.
News Link: Sputnik V Vaccine To Be Produced In India – By MK ( Editor)
